LISATA THERAPEUTICS, INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
LISATA THERAPEUTICS, INC. (LSTA) had Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value of $28.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-22.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue · last filed 2018-03-22
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $28.00K.
- 2017-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
- 2016-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
- 2016-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $500.00.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value |
|---|---|
| 2017-12-31 | $28.00K 10-K · filed 2018-03-22 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 |
| 2016-09-30 | $500.00 10-Q · filed 2016-11-07 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-17 |
| 2015-09-30 | $600.00 10-Q · filed 2015-11-05 |
| 2015-06-30 | $1.80K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-06 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-15 |
| 2014-09-30 | $0.00 10-Q · filed 2014-10-30 |
| 2014-06-30 | -$100.00 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |